175 related articles for article (PubMed ID: 20648435)
1. [CA-125 - does this next biomarker have a chance to hope for an expectation of risk stratification in patients with heart failure?].
Zieliński T
Kardiol Pol; 2010 Jul; 68(7):779-80. PubMed ID: 20648435
[No Abstract] [Full Text] [Related]
2. Prognostic value of pleural effusion, CA-125 and NT-proBNP in patients with acute decompensated heart failure.
Davutoglu V; Yildirim C; Kucukaslan H; Yuce M; Sari I; Tarakcioglu M; Akcay M; Cakici M; Ceylan N; Al B
Kardiol Pol; 2010 Jul; 68(7):771-8. PubMed ID: 20648434
[TBL] [Abstract][Full Text] [Related]
3. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.
Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P
Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808
[TBL] [Abstract][Full Text] [Related]
4. Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center.
Amir O; Paz H; Ammar R; Yaniv N; Schliamser JE; Lewis BS
Isr Med Assoc J; 2008 Feb; 10(2):109-12. PubMed ID: 18432021
[TBL] [Abstract][Full Text] [Related]
5. Amino-terminal pro-brain natriuretic peptide: a biomarker for diagnosis, prognosis and management of heart failure.
Morello AM; Januzzi JL
Expert Rev Mol Diagn; 2006 Sep; 6(5):649-62. PubMed ID: 17009901
[TBL] [Abstract][Full Text] [Related]
6. [Role of BNP in heart failure diagnosis].
Logeart D
Rev Prat; 2010 Sep; 60(7):923. PubMed ID: 21033485
[No Abstract] [Full Text] [Related]
7. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
[TBL] [Abstract][Full Text] [Related]
8. Improving risk stratification for heart failure. A role for serial testing of B-type natriuretic peptides?
Daly MG; Frampton CM; Troughton RW
J Am Coll Cardiol; 2010 Feb; 55(5):451-3. PubMed ID: 20117458
[No Abstract] [Full Text] [Related]
9. N-terminal proBNP: a novel biomarker for the diagnosis, risk stratification and management of congestive heart failure.
O'Donoghue M; Januzzi JL
Expert Rev Cardiovasc Ther; 2005 May; 3(3):487-96. PubMed ID: 15889976
[TBL] [Abstract][Full Text] [Related]
10. Letter by Dinh et al regarding the article, "Simultaneous assessment of unprocessed ProBNP1-108 in addition to processed BNP32 improves identification of high-risk ambulatory patients with heart failure".
Dinh W; Nickl W; Kramer F
Circ Heart Fail; 2010 Jul; 3(4):e26; author reply e27. PubMed ID: 20647485
[No Abstract] [Full Text] [Related]
11. Risk stratification in chronic heart failure: independent and incremental prognostic value of echocardiography and brain natriuretic peptide and its N-terminal fragment.
Bruch C; Rothenburger M; Gotzmann M; Sindermann J; Scheld HH; Breithardt G; Wichter T
J Am Soc Echocardiogr; 2006 May; 19(5):522-8. PubMed ID: 16644435
[TBL] [Abstract][Full Text] [Related]
12. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
[TBL] [Abstract][Full Text] [Related]
13. Are multiple biomarker testing strategies ready for prime time in heart failure?
Lee DS; Tu JV
Circ Heart Fail; 2009 Sep; 2(5):387-8. PubMed ID: 19808366
[No Abstract] [Full Text] [Related]
14. Breathing not properly 10 years later: what we have learned and what we still need to learn.
Maisel AS; Daniels LB
J Am Coll Cardiol; 2012 Jul; 60(4):277-82. PubMed ID: 22813603
[TBL] [Abstract][Full Text] [Related]
15. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure.
Perna ER; Macin SM; Cimbaro Canella JP; Szyszko A; Franciosi V; Vargas Morales W; Bayol AP; Kriskovich JO; Medina F; Gonzalez Arjol B; Brizuela M
J Heart Lung Transplant; 2006 Oct; 25(10):1230-40. PubMed ID: 17045936
[TBL] [Abstract][Full Text] [Related]
16. Plasma NT-proBNP: a new biomarker for diagnosis and monitoring of congestive heart failure (CHF).
Bayes-Genis A
Timely Top Med Cardiovasc Dis; 2006 Apr; 10():E10. PubMed ID: 17066132
[No Abstract] [Full Text] [Related]
17. Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure.
Núñez J; Sanchis J; Bodí V; Fonarow GC; Núñez E; Bertomeu-González V; Miñana G; Consuegra L; Bosch MJ; Carratalá A; Chorro FJ; Llàcer A
Eur Heart J; 2010 Jul; 31(14):1752-63. PubMed ID: 20501480
[TBL] [Abstract][Full Text] [Related]
18. Diagnosing acute heart failure: the mathematician and the clinician.
Dickstein K
J Am Coll Cardiol; 2009 Oct; 54(16):1522-3. PubMed ID: 19815123
[No Abstract] [Full Text] [Related]
19. N-terminal probrain natriuretic peptide as a predictor of short-term outcomes in acute myocardial infarction.
Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
Indian Heart J; 2005; 57(4):304-10. PubMed ID: 16350675
[TBL] [Abstract][Full Text] [Related]
20. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
